Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd (SURAKSHA) last reported results for the quarter ended Jun 2026, with sales of ₹88 crore and net profit of ₹13 crore. The stock last traded at ₹331, a market capitalisation of ₹1,724 crore, on a P/E of 48.2. Over the past 52 weeks the stock has ranged between ₹224 and ₹360. Figures are as of 6 Oct 2026 and are not real time.
Suraksha Diagnostic Ltd share price and key metrics
- Current price
- ₹331
- Market cap
- ₹1,724 cr
- Stock P/E
- 48.2
- Book value
- ₹47
- ROE
- 14.2%
- ROCE
- 17.3%
- Dividend yield
- 0.15%
- 52w high / low
- 360/224
Metrics as of 6 Oct 2026. Not real time.
Track Suraksha Diagnostic Ltd
Cruxal reads every Suraksha Diagnostic Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Suraksha Diagnostic Ltd growth and returns
- 10 Years
- %
- 5 Years
- 17%
- 3 Years
- 18%
- TTM
- 23%
- 10 Years
- %
- 5 Years
- 32%
- 3 Years
- 62%
- TTM
- 8%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 10%
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 15%
- Last Year
- 14%
Suraksha Diagnostic Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹88 cr, up 20.5% from ₹73 cr a year earlier. Net profit was ₹13 cr, up 44.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 |
| Expenses | 44 | 41 | 46 | 49 | 55 | 55 | 57 | 57 |
| Operating profit | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 30 |
| OPM % | 35% | 31% | 29% | 33% | 31% | 30% | 30% | 35% |
| Other income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 |
| Depreciation | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 11 |
| Profit before tax | 14 | 8 | 9 | 12 | 12 | 10 | 10 | 17 |
| Tax % | 26% | 26% | 22% | 26% | 27% | 28% | 38% | 22% |
| Net profit | 10 | 6 | 7 | 9 | 9 | 7 | 6 | 13 |
| EPS (₹) | 2.40 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Suraksha Diagnostic Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 158 | 140 | 223 | 190 | 219 | 252 | 310 | 325 |
| Operating profit | 34 | 25 | 49 | 47 | 73 | 82 | 96 | 102 |
| OPM % | 22% | 18% | 22% | 25% | 33% | 33% | 31% | 31% |
| Net profit | 15 | 6 | 24 | 6 | 23 | 31 | 31 | 35 |
| EPS (₹) | 220.43 | 93.33 | 344.20 | 94.49 | 342.46 | 6.11 | 6.18 | 6.88 |
TTM is the trailing twelve months to the most recent quarter.
Suraksha Diagnostic Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 7 | 7 | 7 | 7 | 7 | 10 | 10 |
| Reserves | 111 | 118 | 141 | 147 | 171 | 201 | 234 |
| Borrowings | 13 | 18 | 21 | 99 | 92 | 89 | 130 |
| Other liabilities | 42 | 28 | 32 | 28 | 30 | 33 | 73 |
| Total liabilities | 173 | 171 | 201 | 281 | 300 | 334 | 448 |
| Fixed assets | 128 | 119 | 119 | 195 | 212 | 223 | 315 |
| CWIP | 0 | 0 | 1 | 2 | 1 | 11 | 37 |
| Investments | 5 | 5 | 0 | 0 | 0 | 1 | 0 |
| Other assets | 39 | 46 | 80 | 84 | 87 | 99 | 97 |
| Total assets | 173 | 171 | 201 | 281 | 300 | 334 | 448 |
As reported by the company. Total assets equal total liabilities by construction.
Suraksha Diagnostic Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | 31 | 24 | 42 | 44 | 60 | 63 | 82 |
| Cash from investing | -20 | -28 | -44 | -21 | -35 | -40 | -52 |
| Cash from financing | -10 | 3 | 1 | -24 | -25 | -24 | -29 |
| Net cash flow | 1 | -1 | -0 | -1 | 0 | -0 | 1 |
| Free cash flow | 15 | 8 | 23 | 32 | 18 | 21 | 15 |
| CFO / operating profit | 111% | 100% | 95% | 109% | 95% | 90% | 99% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Suraksha Diagnostic Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 8% | 24% | 9% | 17% | 18% | 17% |
| Debtor days | 14 | 16 | 12 | 9 | 15 | 20 | 27 |
| Inventory days | 93 | 62 | 38 | 82 | 89 | 100 | 81 |
| Days payable | 227 | 177 | 84 | 187 | 193 | 169 | 209 |
| Cash conversion cycle | -120 | -99 | -34 | -96 | -89 | -49 | -101 |
| Working capital days | -35 | -19 | -15 | -49 | -37 | -23 | -28 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Suraksha Diagnostic Ltd shareholding pattern
Promoters held 49.10% at Jun 2026, broadly unchanged since Jun 2025. FIIs 13.47% and DIIs 23.22%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 48.78% | 48.78% | 48.89% | 48.98% | 49.00% | 49.10% | 49.10% |
| FIIs | 15.39% | 14.46% | 13.95% | 13.73% | 13.46% | 13.46% | 13.47% |
| DIIs | 20.43% | 22.05% | 22.37% | 21.98% | 22.57% | 23.14% | 23.22% |
| Public | 15.39% | 14.71% | 14.79% | 15.30% | 14.98% | 14.31% | 14.20% |
| No. of shareholders | 98,662 | 87,275 | 79,670 | 75,304 | 70,963 | 67,107 | 64,866 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Suraksha Diagnostic Ltd corporate filings
- Certificate under Regulation 74(5) of SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended 30 September, 2026.Company Updatelow impact
- Pursuant to provision of SEBI (Prohibition of Insider Trading) Regulation, 2015 as amended from time to time, we wish to inform you that in terms of the Company''s Code of Conduct for regulation, ....Insider Trading / SASTlow impact
- Suraksha Diagnostic Limited concludes 21st AGM; shareholders approve final dividend of INR 0.50 per shareAGM/EGMlow impact
Cruxal's analysis: Suraksha Diagnostic Limited has successfully concluded its 21st Annual General Meeting…
Read the full analysis - Suraksha Diagnostic Limited concludes 21st AGM; shareholders approve final dividend of 0.50 INR per shareAGM/EGMlow impact
Cruxal's analysis: Suraksha Diagnostic Limited has successfully concluded its 21st Annual General Meeting…
Read the full analysis - Suraksha Diagnostic Limited concludes 21st AGM; declares final dividend of INR 0.50 per shareAGM/EGMlow impact
Cruxal's analysis: Suraksha Diagnostic Limited has successfully concluded its 21st Annual General Meeting…
Read the full analysis - Suraksha Diagnostic Ltd announces 21st Annual General Meeting and e-voting detailsCompany Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has published a newspaper advertisement regarding its 21st Annual…
Read the full analysis - Suraksha Diagnostic Ltd issues notice for Annual Report access for FY 2025-26Company Updatelow impact
Cruxal's analysis: The company has issued a formal communication to shareholders who have not registered…
Read the full analysis - Suraksha Diagnostic Limited Announces FY 2025-26 Annual Report and Dividend DeclarationOthershigh impact
Cruxal's analysis: Suraksha Diagnostic Limited has released its Annual Report for FY 2025-26, reporting a…
Read the full analysis - Suraksha Diagnostic Limited Announces 21st Annual General Meeting Scheduled for 22 September 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has issued a formal notice for its 21st Annual General…
Read the full analysis - Suraksha Diagnostic Limited Announces 21st Annual General Meeting for September 22, 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has issued a formal notice for its 21st Annual General…
Read the full analysis - Suraksha Diagnostic Reports Strong Q1 FY27 Performance with 21% Revenue Growth and 40% PAT SurgeCompany Updatehigh impact
Cruxal's analysis: Suraksha Diagnostic Limited reported a robust start to FY27, with Q1 revenue reaching INR…
Read the full analysis - Suraksha Diagnostic Ltd releases audio recording of analyst/institutional investor earnings call held on 13 August 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has filed the intimation regarding the availability of the audio…
Read the full analysis - Suraksha Diagnostic Ltd releases audio recording of earnings call held on August 13, 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has filed the audio recording of its analyst and institutional…
Read the full analysis - Suraksha Diagnostic Limited reports Q1 FY27 financial results; standalone and consolidated results publishedCompany Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has formally published its unaudited standalone and…
Read the full analysis - Suraksha Diagnostic Limited Reports Strong Q1 FY27 Performance with 21% Revenue Growth and 40% PAT ExpansionCompany Updatehigh impact
Cruxal's analysis: Suraksha Diagnostic Limited delivered a robust Q1 FY27, reporting revenue from operations…
Read the full analysis - Suraksha Diagnostic Limited Reports Strong Q1 FY27 Results with 40% YoY PAT Growth and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Suraksha Diagnostic Limited delivered a robust performance for the quarter ended 30 June…
Read the full analysis - Suraksha Diagnostic Ltd fixes revised record date for corporate action on 15 September 2026Corp. Actionlow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has announced a revision to its record date, now fixed for 15…
Read the full analysis - Suraksha Diagnostic Limited Reports Strong Q1 FY27 Financials and Appoints New Group CFOBoard Meetinghigh impact
Cruxal's analysis: Suraksha Diagnostic Limited reported robust standalone financial results for the quarter…
Read the full analysis - Suraksha Diagnostic Limited announces postponement of 21st Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Suraksha Diagnostic Limited has formally notified the stock exchanges regarding the…
Read the full analysis - Suraksha Diagnostic Limited schedules Q1 FY27 earnings conference call for 13 August 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has announced an earnings conference call scheduled for 13…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.